baber/WOPTO huggingface dataset:
Patent CA-2536896-A1 (CA)
Inventor: OHLSSON BJORN JONAS
IPC: G01N23/00
Filed: 2004-01-07
Abstract: A probe structure for a scanning probe microscope comprises a nanowhisker (16,34) projecting from a free end of an upstanding tip member (4,26), and being formed integrally with the tip member. In another embodiment, a data storage medium comprises an array of nanowhiskers (54), each nanowhisker being formed from magnetic material, the diameter of the nanowhisker being such that a single ferromagnetic domain exists within the nanowhisker, preferably having a diameter not greater than about 25 nm and more preferably not greater than about 10 nm, and a read/write structure comprising the probe structure for injecting a stream of spin-polarised electrons into a selected nanowhisker of the array, either for sensing the direction of magnetisation in the nanowhisker, or for forcing the nanowhisker into a desired direction of magnetisation. When the probe nanowhisker is formed by a VLS process using a catalytic particle melt, the whisker may be formed with a sacrificial segment to allow for removal of the catalytic material by selective etching of the segment.
Patent CA-2545042-A1 (CA)
Inventor: BROWN RORK S
IPC: G05D1/10
Filed: 2006-04-26
Abstract: A method for optimizing the flight path of an aircraft is performed by collecting atmospheric information data from one or more sensors mounted on an aircraft; processing the collected atmospheric information; predicting an atmospheric condition in a flight path of the aircraft based upon the collected atmospheric information; and modifying the flight path in anticipation of the atmospheric condition.
Patent CA-2545681-A1 (CA)
Inventor: RUANE MARK A
IPC: G06Q30/00
Filed: 2004-11-24
Abstract: Publié sans précis
Patent CA-2547394-A1 (CA)
Title: New pharmaceutical compositions based on a scopineester and nicotinamide derivatives
Inventor: PIEPER MICHAEL P
IPC: A61K31/46
Filed: 2005-01-04
Abstract: The present invention relates to novel pharmaceutical compositions based on a scopineester of formula (1) wherein X- has the meanings specified in the description and claims and one ore more, preferably one nicotinamide derivative, processes for preparing them and their use in the treatment of respiratory diseases.
Patent CA-2548707-A1 (CA)
Inventor: GARRETT RICK
IPC: H04Q1/20
Filed: 2006-05-29
Abstract: Embodiments of a digital cross-connect panel with tracer lamps for identifying telecommunications circuits are presented herein.
Patent CA-2553795-A1 (CA)
Title: Eccentric screw pump with integrated drive
Inventor: JABERG HELMUT
IPC: F04C15/06
Filed: 2005-07-15
Abstract: The invention relates to an eccentric screw pump which comprises a stator (2) and a rotor (1) rotating therein as well as a drive motor for driving the rotor. The armature (3) of the drive motor is non-rotationally linked with the rotor and rotates inside a cylindrical pot (5) on an eccentric orbit. The torque for driving the rotor is generated by means of a stator winding (4).
Patent CA-2555275-A1 (CA)
Inventor: PATNO BRIAN E
IPC: G07B15/00
Filed: 2005-08-18
Abstract: La présente invention se rapporte à un lecteur mobile d'application (MER), qui comprend une antenne, un lecteur couplé de manière à recevoir des signaux de l'antenne, et une unité de commande/affichage (CDU) couplée au lecteur. La CDU sélectionne une direction de réception et traite des signaux fournis dans cette dernière à partir du lecteur. Lorsque le MER et un transpondeur sont à proximité l'un de l'autre, le MER interroge le transpondeur et reçoit des informations liées au paiement du droit de péage. Le MER autorise des agents d'application à superviser le paiement de véhicules à passager unique (SOV) pour que ces derniers puissent emprunter des voies réservées aux véhicules à occupation multiples (HOT).
Patent CA-2558670-A1 (CA)
Inventor: TOPHAM DAVID J
IPC: G01N33/53
Filed: 2005-02-16
Abstract: Disclosed are methods for evaluating efficacy of an immune response by assessing alpha-l integrin, screening for, and manufacturing those therapeutic agents. Described herein the presence of VLA-1+ (positive) T cells indicates an effective immune response. Also disclosed are methods of screening for antigens that induce the production of VLA-1+ (positive) T cells, methods of isolating the antigens, and methods using the antigens identified in the screening methods to treat a subject with a disease.
Patent CA-2559220-A1 (CA)
Inventor: MARUMOTO TOSHIAKI
IPC: F16L59/06
Filed: 2005-03-09
Abstract: [PROBLEMS] A hollow structure member having a certain air layer to improve heat insulating performance and buffering performance, and having a small volume when collapsed with a gas released. [MEANS FOR SOLVING PROBLEMS] A  hollow structure member has two sheet members (11, 12) constituting at least a part of an air- tight structure body and oppositely arranged and has an air-permeable sheet member (13) having air permeability and alternately bonded to opposite surfaces of the two sheet members (11, 12). The periphery of the sheet members (11, 12) is bonded and a gas supply opening through which a gas can be charged and discharged is provided.
Patent CA-2561613-A1 (CA)
Title: A patient ventilating and aspirating system
Inventor: EDIRISURIYA DESHITHA AIRAWANA
IPC: A61M16/08
Filed: 2005-03-30
Abstract: A patient ventilating (23) and aspirating system (8) is disclosed that has a suction tube (9) and connector (6) for connecting to a catheter mount that has a sealed passageway (15). The catheter mount passageway (15) is sealed with an elastomeric seal (16) including a perforation or slit (17). A connector (12) with a piercing member is associated with the suction tube (9). When the connector is attached to the catheter mount the piercing member (20) pierces the seal (16) such that the suction tube (9) can pass through the connector (6) and catheter mount.
Patent CA-2563243-A1 (CA)
Inventor: O'BRIEN JOHN MICHAEL
IPC: B60C11/14
Filed: 2004-10-27
Abstract: A tire structure (16) includes a secondary chamber (32) formed between a tire casing (38) and road engaging tire tread (14). A first air passage (20) is provided from the tire interior to the secondary chamber (32) and a second air passage (24) through a side wall of the tire casing (38) is substantially adjacent a bead portion of the tire. An air line (22) extends between the two air passages (20, 24) and is bonded to the interior side wall of the casing (38), and a valve unit (26) is associated with the second passage (24) to provide controlled air inlet and relief to the chamber (32).
Patent CA-2563966-A1 (CA)
Title: Energy price lock
Inventor: HASSE KARL MARTIN
IPC: G06Q30/06
Filed: 2006-09-01
Abstract: ABSTRACT OF INVENTION FOR CONSUMERS, COMMERCIAL CONSUMERS, TRANSPORTATION COMPANIES, TRUCK DRIVERS, MUNICIPALITIES, PROVINCIAL  AND FEDERAL GOVERNMNETS TO 'LOCK IN' OR FIX GAS, DIESEL, HYDROCARBONS OR ELECTRICITY PRICES PER LITRE OR KILLOWATT (OR  WHATEVER OTHER MEASUREMENT) AT RETAIL OR COMMERCIAL GAS  STATIONS TO SAVE MONEY ON FLUCTUATING GAS, DIESEL PRICES, HYDROCARBON, ELECTRICITY PRICES OR ENERGY PRICES.
Patent CA-2565173-A1 (CA)
Title: Interleukin-11 fusion proteins
Inventor: WEIMER T
IPC: C07K14/76
Filed: 2004-12-03
Abstract: The invention relates to proteins comprising Interleukin 11 (IL-11) (including, but not limited to, fragments and variants thereof), which exhibit thrombopoietic or antiinflammatory properties, fused to albumin (including, but not limited to fragments or variants of albumin). These fusion proteins are herein collectively referred to as "albumin fusion proteins of the invention". These fusion proteins exhibit extended shelf-life and/ or pharmacokinetic properties and/or extended or therapeutic activity. The invention encompasses therapeutic albumin fusion proteins, compositions, pharmaceutical compositions, formulations and kits. The invention also encompasses nucleic acid molecules encoding the albumin fusion proteins of the invention, as well as vectors containing these nucleic acids, host cells transformed with these nucleic acids and vectors, and methods of making the albumin fusion proteins of the invention using these nucleic acids, vectors, and/or host cells. The invention also relates to compositions and methods for treatment or prophylaxis of thrombocytopenia or inflammatory diseases.
Patent CA-2566435-A1 (CA)
Title: Antimicrobial acid-catalyzed coating compositions
Inventor: BRAY JAMES H III
IPC: C08G63/02
Filed: 2005-05-10
Abstract: The antimicrobial acid-catalyzed coating composition of the invention is an acid~catalyzed coating composition formulated with at least one antimicrobial agent to provide antimicrobial activity to the coating composition and an article coated therewith.
Patent CA-2566815-A1 (CA)
Title: Frontal affinity chromatography/maldi tandem mass spectrometry
Inventor: COVEY TOM R
IPC: G01N30/72
Filed: 2005-05-24
Abstract: Sol-gel derived monolithic silica columns containing entrapped dihydrofolate reductase were used for frontal affinity chromatography of small molecule mixtures. The output from the column combined with a second stream containing the matrix molecule (HCCA) and was directly deposited onto a conventional MALDI plate that moved relative to the column via a computer controlled x-y stage, creating a semi-permanent record of the FAC run. The use of MALDI MS  allowed for a decoupling of the FAC and MS methods allowing significantly higher ionic strength buffers to be used for FAC studies, which allowed for better retention of protein activity over multiple runs.
Patent CA-2567419-A1 (CA)
Title: System and method for multi-resolution fairing of non-manifold models
Inventor: HUBELI ANDREAS GIOVANNI PIERO
IPC: G06T17/00
Filed: 2001-01-05
Abstract: A method of fairing a non-manifold model as disclosed which includes smoothing the model by applying a fairing operator to a set of features such that noise is removed after determining the features of the model.
Patent CA-2570179-A1 (CA)
Title: Method for producing acetamidopyrrolidine derivative and intermediate compound thereof
Inventor: TAKEYASU TAKUMI
IPC: C07C231/02
Filed: 2005-06-13
Abstract: Disclosed is a method for producing an acetamidopyrrolidine derivative or a salt thereof comprising a reaction process expressed by the following formulae. Formulae In the formulae, R1 represents a hydrogen atom or a C1-C6 alkyl group; R13, R14, R15 and R16 independently represent a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 alkoxy group, a hydroxy group, a C1-C6 halogenated alkyl group or a C1-C6 halogenated alkoxy group; and R21 represents an ester-protecting group.
Patent CA-2572543-A1 (CA)
Title: Ball trap
Inventor: WHITEFIELD KEVIN
IPC: A63B63/06
Filed: 2005-06-08
Abstract: A ball trap comprises a carrier about which is spaced a number of suspended flaps so as to be positioned, in use, about the surface on which the ball travels and which are configured, so that when a-or the-flap is impacted by a ball, the flap is pushed aside to a position where, provided the impact force is sufficient, the ball passes underneath the flap and the flap falls back to its position of rest to prevent the ball from escaping; characterised by the feature that the flap region which the ball pushes aside on impact is spaced sufficiently, radially outward from the carrier that the same region can subsequently corne down behind the ball and act as the escape-preventing means.
Patent CA-2575781-A1 (CA)
Inventor: SCHNEIDER WILLI
IPC: F04C18/344
Filed: 2005-04-20
Abstract: The invention relates to a single-winged vacuum pump provided with a pot-shaped housing (12), a rotor (18) which is mounted in a rotational and eccentric manner in the housing, and a wing which is displacably mounted in the rotor and which is orthogonal on the rotational axis (21), whereby the points of the wing (34) are placed on a peripheral surface (32) which defines a work chamber. The invention is characterised in that one part of the peripheral surface (32) is formed by an insert and the rotor (18) touches the insert.
Patent CA-2576217-A1 (CA)
Title: Selective vpac2 receptor peptide agonists
Inventor: BOKVIST BENGT KRISTER
IPC: C07K14/435
Filed: 2005-08-11
Abstract: SELECTIVE VPAC2 RECEPTOR PEPTIDE AGONISTS The present invention relates to peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.
Patent CA-2577068-A1 (CA)
Inventor: HO DAVID
IPC: G01N33/86
Filed: 2005-08-12
Abstract: The present invention provides processes for preparing freeze-dried platelets, freeze-dried platelets made by those processes, platelets reconstituted from those freeze-dried platelets, methods of using the platelets for therapeutic, diagnostic, and research purposes, and kits comprising the freeze-dried platelets.
Patent CA-2577651-A1 (CA)
Title: Metal-mediated viscosity reduction of fluids gelled with viscoelastic surfactants
Inventor: CREWS JAMES B
IPC: E21B43/25
Filed: 2005-06-07
Abstract: Fluids viscosified with viscoelastic surfactants (VESs) may have their viscosities reduced (gels broken) by the direct or indirect action of a composition that contains at least one metal ion source and optionally at least one second source. An optional second source may be a chelating agent where at least one reducing agent source may be additionally optionally used.  Another optional component with the metal ion source includes a second, different metal ion source. The breaking composition is believed to directly attack the VES itself, possibly by disaggregating or otherwise attacking the micellar structure of the VES-gelled fluid, and/or possibly by changing the chemical structure of the VES to give two or more products.
Patent CA-2577900-A1 (CA)
Title: Cantilevered shoe construction
Inventor: KERRIGAN D CASEY
IPC: A43B7/22
Filed: 2005-09-26
Abstract: A foot support (50) includes a foot supporting structure (58) having a lateral side (20) and a medial side (22). The foot supporting structure (58) is adapted to provide support to the underside of weight-bearing portions of a user~s foot. An anchoring structure (59) beneath the foot supporting structure (58) is connected to the lateral side (20) of the foot supporting structure (58) and not connected to the medial side (22) so that the medial side (22) of the foot supporting structure (58) forms a cantilever arm projecting out from the lateral side (20).
Patent CA-2579264-A1 (CA)
Title: Composite article
Inventor: SNIDER DANNY
IPC: B29C43/20
Filed: 2007-02-21
Abstract: A composite includes a first preform and a second preform spaced from and in overlying relationship to the first preform. The second preform defines at least one first opening extending therethrough along an axis transverse to the first preform.  A first surface layer is disposed adjacent to the second preform and on an opposite side of the second preform from the first preform. A polymeric composition including the reaction product of an isocyanate component and an isocyanate-reactive component is disposed between the first preform and the second preform. The polymeric composition adheres the first surface layer to the second preform through the at least one first opening. The surface layer is adhered to the second preform during molding of the composite article and in the absence of additional adhesive, thereby reducing production time and cost of the composite article.
Patent CA-2579866-A1 (CA)
Inventor: BUCKLEY DANIEL T
IPC: H01M8/10
Filed: 2007-02-27
Abstract: The present invention relates to the resultant products, the method and apparatus to produce electrochemical cell parts using a material deposition process or processes and specially developed inks appropriate to the specific application requirements at each location on the bipolar plate and can include the gas diffusion layer and the specific deposition of the catalyst and the seals.
Patent CA-2580991-A1 (CA)
Inventor: MCQUAID SARAH
IPC: A61K38/22
Filed: 2005-10-11
Abstract: The present invention relates to Amylin Family Polypeptide-6 (AFP-6) analogs, which include derivatives and fragments, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the AFP-6 analogs. The AFP-6 analogs of the invention include one or more amino acid sequence modifications. In addition, methods and compositions are disclosed to treat and prevent conditions such as metabolic and cardiovascular disorders, e.g., obesity, diabetes, metabolic syndrome, myocardial ischemia, and increased cardiovascular risk.
Patent CA-2582412-A1 (CA)
Title: Pesticidal mixtures
Inventor: HOLMES KEITH A
IPC: A01N43/40
Filed: 2005-10-20
Abstract: Pesticidal mixtures comprising, as active components, 1) an 1-arylpyrazole of the formula (I) wherein R1 is CN, C(=O)C1-C4-alkyl, or C(=S)NH2; R2 is S(O)nR3; R3 is C1-C6-alkyl; R4 is hydrogen, halogen, amino, C1-C6-alkylamino, di(C1-C6-alkyl)amino, or 4-hydroxy-3-methoxybenzylideneamino); W is N or CR5;  R5, R6 and R7 are, each independently, hydrogen, halogen, or C1-C6-haloalkyl;  n is 0, 1 or 2; or its salts and 2) a compound of the formula (II), or its salts, in synergistically effective amounts; use of this mixture for combating insects, arachnids, or nematodes; method for protecting plants against these pests; and method for treating, controlling, preventing or protecting a warm-blooded animal or a fish against infestation or infection by pests which comprises orally, topically or parenterally administering or applying to said animal or fish a pesticidally effective amount of this mixture.
Patent CA-2582856-A1 (CA)
Inventor: FRUGIER ALAIN
IPC: A61M1/36
Filed: 2000-01-11
Abstract: An integrated CRRT method and apparatus (10) incorporates steps and means for compensating for heat loss from blood in an extracorporeal circuit. A blood warmer (20) is designed to engage and hold a disposable blood tube segment to transfer heat at a closely controlled temperature to blood flowing in the disposable blood tube segment. Another significant aspect of the present invention is a blood tube segment for engagement with the blood warmer (20) is located in downstream of a dialyzer and upstream of a venous pressure monitor (15), an air bubble detector (90) and a venous line clamp (95). The disposable blood tube segment may be selectively connected when heat loss compensation is required and left disconnected when heat loss compensation is not required.
Patent CA-2584483-A1 (CA)
Title: Tubular structure based on hyaluronic acid derivatives for vascular and urethral graft
Inventor: ABATANGELO GIOVANNI
IPC: A61L27/20
Filed: 2005-10-27
Abstract: Tubular structure, whose wall has an unbroken surface consisting essentially of at least one HA derivative and optionally a further polymer of natural, synthetic or semisynthetic origin. Said tubular structure, which is prepared with a very simple process, is used for the preparation of vascular and urethral grafts.
Patent CA-2585632-A1 (CA)
Inventor: FORTIER ANDRE
IPC: B26B23/00
Filed: 2007-04-20
Abstract: A hand tool and a method of fabrication thereof, the tool comprising a head having a neck portion provided with perforations, and a handle comprising a core and a sleeve, the sleeve of the handle being molded over the core and the neck, the material of the sleeve forming a bridge between the core and the neck and filling the perforations of the neck.
Patent CA-2585728-A1 (CA)
Title: Aluminum articles with wear-resistant coatings and methods for applying the coatings onto the articles
Inventor: RAYBOULD DEREK
IPC: C23C24/04
Filed: 2005-10-28
Abstract: A method for coating a surface of a component formed from aluminum or an alloy thereof includes the step (204) of cold gas-dynamic spraying a powder material on the component surface to form a coating, the powder material comprising at least one alloy from the group consisting of titanium, a titanium alloy, nickel, a nickel alloy, iron, an iron alloy, aluminum, an aluminum alloy, copper, a copper alloy, cobalt, and a cobalt alloy. In one embodiment, the method further includes the step (210) of heat treating the turbine component after the cold gas-dynamic spraying.
Patent CA-2592104-A1 (CA)
Inventor: UDAGAWA HIROAKI
IPC: C12N9/32
Filed: 2005-12-22
Abstract: The present invention relates to polypeptides comprising a carbohydrate-binding module amino acid sequence and an alpha-amylase amino acid sequence as well as to the application of such polypeptides.
Patent CA-2595461-A1 (CA)
Inventor: MUELBAIER MARCEL
IPC: C07K14/765
Filed: 2006-01-20
Abstract: The present invention is directed to a Gyrase inhibitor-protein conjugate; in particular a Gyrase inhibitor-albumin conjugate. The present invention further provides methods of the treatment of inflammatory conditions and tumors. Methods of making and producing a Gyrase inhibitor-protein conjugate are also disclosed.
Patent CA-2604792-A1 (CA)
Title: Hollow fiber membrane module, and method for producing the hollow fiber membrane module
Inventor: HAYASHI TAKAHIRO
IPC: B01D63/00
Filed: 2006-02-23
Abstract: A hollow fiber membrane module enabling the simplification of its structure and the recycling of its housing and a method of manufacturing the hollow fiber membrane module. The hollow fiber membrane module (100) comprises a plurality of hollow fiber membranes (11), a hollow fiber membrane unit (10) having a first sealingly fixing part (12) and a second sealingly fixing part (13) sealingly fixing both end parts of these hollow fiber membranes (11) so that the inside of the hollows thereof can be opened and formed so that the outer wall surfaces of these sealingly fixing parts can be exposed, and the housing (20) in which the hollow fiber membrane unit (10) is stored. The housing (20) comprises first ports (22a) and (23a) forming flow passages led to the inside of the hollows of the hollow fiber membranes (11) and second ports (21a) and (21b) forming flow passages led to the outer wall surface side of the hollow fiber membranes (11). The hollow fiber membrane unit (10) is characterized in that it is formed detachable from the housing (20).
Patent CA-2605430-A1 (CA)
Inventor: FONTCUBERTA PHILIPPE
IPC: A61L2/08
Filed: 2006-04-19
Abstract: L'invention se rapporte à une installation (1) pour la stérilisation d'objet s par bombardement d'électrons, cette installation comprenant un premier convoyeur (6) ainsi qu'un second convoyeur (30) conçus pour déplacer les objets (2) et étant respectivement situés de part et d'autre d'une chambre d e traitement (14) . Selon l'invention, l'installation est munie d'une part d'u n tourniquet transporteur d'entrée (8) conçu pour déplacer les objets et étant interposé entre le premier convoyeur et la chambre (14) , et d'autre part d' un tourniquet transporteur de sortie (24) également conçu pour déplacer les objets et étant interposé entre la chambre (14) et le second convoyeur.</SDO AB>
Patent CA-2610055-A1 (CA)
Title: Synergistic fungicidal compositions
Inventor: FILIPPINI LUCIO
IPC: A01N25/00
Filed: 2006-05-29
Abstract: Fungicidal compositions are described, consisting of mixtures comprising a copper (II) salt of phosphorous acid and at least another metallic salt of phosphorous acid or consisting of mixtures comprising a copper (II) salt of phosphorous acid, alone or mixed with at least another metallic salt of phosphorous acid, and one or more fungicidal compounds, and their use for the control of phytopathogen fungi .
Patent CA-2610437-A1 (CA)
Inventor: EHRET ANNE
IPC: G01N21/64
Filed: 2006-05-24
Abstract: A method and apparatus for detecting Chemical Warfare Agents (CWA) and Tox ic Industrial Chemicals (TICs) that is simple, cost-effective, non-instrumental , and environmentally robust. Illustrative embodiments provide a material that responds by a color change and/or a change in fluorescence when exposed to the toxic chemical vapors.